-
1
-
-
0032911476
-
Tacrolimus: Effects and side effects
-
Green M.D., Michaels M.G. Tacrolimus Effects and side effects . Pediatr Infect Dis. 18:(4):1999;372-373.
-
(1999)
Pediatr Infect Dis
, vol.18
, Issue.4
, pp. 372-373
-
-
Green, M.D.1
Michaels, M.G.2
-
3
-
-
0028985543
-
FK506 (tacrolimus) compared with cyclosporine for primary immunosuppression after pediatric liver transplantation
-
McDiarmid S.V., Busuttil N.L., Ascher J., et al. FK506 (tacrolimus) compared with cyclosporine for primary immunosuppression after pediatric liver transplantation. Transplantation. 59:1995;530-536.
-
(1995)
Transplantation
, vol.59
, pp. 530-536
-
-
McDiarmid, S.V.1
Busuttil, N.L.2
Ascher, J.3
-
4
-
-
0028294556
-
FK506-induced neurotoxicity in liver transplantation
-
Eelco F.M., Wijdicks M.D., Wiesner M.D., Dahlke L.J., Krom R.A. FK506-induced neurotoxicity in liver transplantation. AnnNeurol. 35:1994;498-501.
-
(1994)
AnnNeurol
, vol.35
, pp. 498-501
-
-
Eelco, F.M.1
Wijdicks, M.D.2
Wiesner, M.D.3
Dahlke, L.J.4
Krom, R.A.5
-
5
-
-
0031609662
-
Efficacy and safety of oral low dose tacrolimus treatment in liver transplantation
-
Margarit C., Rimola A., Gonzalez-Pinto I., et al. Efficacy and safety of oral low dose tacrolimus treatment in liver transplantation. Transpl Int. 11:1998;S260-S266.
-
(1998)
Transpl Int
, vol.11
-
-
Margarit, C.1
Rimola, A.2
Gonzalez-Pinto, I.3
-
7
-
-
0025687691
-
Expressive dysphasia possibly related to FK506 in two liver transplant recipients
-
Reyes J., Gayowski T., Fung J., Todo S., Alessani M., Starzl T.E. Expressive dysphasia possibly related to FK506 in two liver transplant recipients. Transplantation. 50:1990;1043-1044.
-
(1990)
Transplantation
, vol.50
, pp. 1043-1044
-
-
Reyes, J.1
Gayowski, T.2
Fung, J.3
Todo, S.4
Alessani, M.5
Starzl, T.E.6
-
9
-
-
0034721479
-
Tacrolimus-associated mutism after orthotopic liver transplantation
-
Bronster D.J., Gurkan A., Buchsbaum MS Emre S. Tacrolimus-associated mutism after orthotopic liver transplantation. Transplantation. 70:2000;979-982.
-
(2000)
Transplantation
, vol.70
, pp. 979-982
-
-
Bronster, D.J.1
Gurkan, A.2
Buchsbaum MS Emre, S.3
-
10
-
-
0034124476
-
Treatment of tacrolimus-related adverse effects by conversion to cyclosporine in liver transplant recipients
-
Emre S., Genyk Y., Schluger L.K., et al. Treatment of tacrolimus-related adverse effects by conversion to cyclosporine in liver transplant recipients. Transpl Int. 13:2000;73-78.
-
(2000)
Transpl Int
, vol.13
, pp. 73-78
-
-
Emre, S.1
Genyk, Y.2
Schluger, L.K.3
-
11
-
-
0028940457
-
Loss of speech after orthotopic liver transplantation
-
Bronster D.J., Boccagni P., O'Rourke M., Emre S., Schwartz M., Miller C. Loss of speech after orthotopic liver transplantation. Transpl Int. 8:1995;234-237.
-
(1995)
Transpl Int
, vol.8
, pp. 234-237
-
-
Bronster, D.J.1
Boccagni, P.2
O'Rourke, M.3
Emre, S.4
Schwartz, M.5
Miller, C.6
-
13
-
-
0033391636
-
Posterior fossa syndrome: Identifiable risk factors and irreversible complications
-
Doxey D., Bruce D., Sklar F., Swift D., Shapiro K. Posterior fossa syndrome Identifiable risk factors and irreversible complications . Pediatr Neurosurg. 31:1999;131-136.
-
(1999)
Pediatr Neurosurg
, vol.31
, pp. 131-136
-
-
Doxey, D.1
Bruce, D.2
Sklar, F.3
Swift, D.4
Shapiro, K.5
-
14
-
-
13344284635
-
A reversible posterior leukoencephalopathy syndrome
-
Hinchey J., Chaves C., Appignani B., et al. A reversible posterior leukoencephalopathy syndrome. N Engl J Med. 334:1996;494-500.
-
(1996)
N Engl J Med
, vol.334
, pp. 494-500
-
-
Hinchey, J.1
Chaves, C.2
Appignani, B.3
-
15
-
-
0021843544
-
Reversible chronic cerebellar ataxia after phenytoin intoxication: Possible role of cerebellum in cognitive thought
-
Botez M.I., Gravel J., Ezzedine A., Vezina J. Reversible chronic cerebellar ataxia after phenytoin intoxication Possible role of cerebellum in cognitive thought . Neurology. 35:1985;1152-1157.
-
(1985)
Neurology
, vol.35
, pp. 1152-1157
-
-
Botez, M.I.1
Gravel, J.2
Ezzedine, A.3
Vezina, J.4
|